About Index Trending news
Analyze
Top 50 Pricing
Intercept Pharmaceuticals

Intercept Pharmaceuticals

Work at Intercept Pharmaceuticals? Add yourself to this profile

Intercept Pharmaceuticals

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$338,400,000
Venture capital (Series C)
$30,000,000
Employees

Unknown size

Locations
HQ
The Motley Fool

Why Lumber Liquidators, SolarCity, and Intercept Pharmaceuticals Jumped Today

Stock markets Energy
The Motley Fool

Why Intercept Pharmaceuticals Inc is Skyrocketing Today

Stock markets
The Motley Fool

Intercept Pharmaceuticals Sold Off in December, and Here's Why --

Stock markets Health